24
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6704 |
TG 100713
TG100713 |
PI3K | PI3K/Akt/mTOR signaling |
TG 100713 是一种PI3K 的抑制剂,抑制PI3Kδ,γ,α和β的IC50值分别为24、50、165 和 215 nM。 | |||
T3065 |
TG101209
|
Apoptosis; FLT; c-RET; JAK; Autophagy | Angiogenesis; Apoptosis; Autophagy; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
TG101209 是一种选择性有效的 JAK2抑制剂,IC50值为 6 nM。它能抑制 Flt3和RET 的活性,IC50值分别为 25 nM 和 17 nM。 | |||
T13157 |
TG 100801
TG100801,TG 100572 |
VEGFR; Src | Angiogenesis; Tyrosine Kinase/Adaptors |
TG 100801 是 VEGFr2 和 Src 家族(Src 和 YES)激酶的双重抑制剂,是治疗年龄相关性黄斑变性(AMD)的候选化合物。 | |||
T20743 |
TG-46
TG46,TG 46 |
FLT; JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
TG-46 (TG46) 对 JAK2, FLT3, RET, JAK3 具有抑制作用,可用于研究青光眼。 | |||
T2428 |
TG6-10-1
|
5-HT Receptor; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
TG6-10-1 是一种 EP2 拮抗剂。 | |||
T1901 |
(E/Z)-TG003
TG003 |
BCL; CDK | Apoptosis; Cell Cycle/Checkpoint |
(E/Z)-TG003 是一种有效的 ATP 竞争性 Cdc2 样激酶 (Clk) 抑制剂,抑制 Clk1 和 Clk4 的 IC50值分别为 20 和 15 nM。它是 (Z)-TG003 和 (E)-TG003的消旋体。 | |||
T20742 |
TG-89
|
FLT; c-RET; JAK | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
TG-89是 JAK2、JAK3、RET 和 FLT3的抑制剂,对 JAK2的 IC50值为11.2 μM,在卵巢癌和宫颈癌的治疗中显示出抗癌活性。 | |||
T13156L |
TG 100572 Hydrochloride
|
VEGFR; FGFR; PDGFR; Src | Angiogenesis; Tyrosine Kinase/Adaptors |
TG 100572 Hydrochloride 是一种多靶点激酶抑制剂,能够抑制受体酪氨酸激酶和Src 激酶。 | |||
T5482 |
TG4-155
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
TG4-155 是一种脑渗透性 EP2 拮抗剂,对 EP2 和 DP1 具有低纳摩尔的拮抗活性。它作用于 EP2 的 KB 为 2.4 nM,比对 DP1 受体的选择性高 14 倍,比对 EP1、EP3、EP4 和 IP 的选择性比高 550-4750 倍。 | |||
T2672 |
TG100-115
|
PI3K | PI3K/Akt/mTOR signaling |
TG100-115 是 PI3Kγ/PI3Kδ 的选择性抑制剂,IC50分别为 83 和 235 nM。 | |||
T28958 |
TG6-129
TG6 129 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
TG6-129 是有效的EP2受体选择性拮抗剂,可降低 butaprost 诱导的 P388D1 巨噬细胞中炎症因子的表达。 | |||
T74800 | HAT-SIL-TG-1&AT | ||
HAT-SIL-TG-1&AT 是一种 Janus 酪氨酸激酶 (JAK) 抑制剂,具有抗肿瘤作用。HAT-SIL-TG-1&AT 是缺氧激活的前药,可抑制肿瘤组织中的JAK-STAT 信号传导。HAT-SIL-TG-1&AT 在低氧条件下抑制 HEL 细胞增殖并下调磷酸化的STAT3/5。 | |||
T60274 |
TG-2-IN-1
|
||
TG-2-IN-1 (Compound D003) 是一种转谷氨酰胺酶-2 (TGM-2) 抑制剂,可用于近视研究。 | |||
T60367 |
TG003
|
||
TG003 是一种有效的 Clk1/Sty 抑制剂,抑制 Clk1 和 Clk4 的 IC50值分别为 20 和 15 nM。 | |||
T66481 |
TG-693
|
||
TG693, an orally available inhibitor of CLK1, promotes the skipping of the endogenous mutated exon 31 in Duchenne muscular dystrophy (DMD) patient-derived cells and increased the production of the functional exon 31-skipped dystrophin protein. | |||
T71652 |
TG100948
|
||
TG100948 is a novel dual VEGFR/Src kinase inhibitor. | |||
T83855 |
TG2-179-1
|
||
TG2-179-1是BRCA1相关蛋白1(BAP1)的抑制剂。它在25 µM至1.5 mM的浓度范围内,通过无细胞测定法抑制BAP1的去泛素化活性。TG2-179-1对八种结肠癌细胞系表现出细胞毒性(IC50s = 4.48-7.52 µM)。在体内,TG2-179-1(10和30 mg/kg)能够减少HCT116结肠癌小鼠异种移植模型中的肿瘤体积。 | |||
T69608 |
TG11-77 HCl
|
||
TG11-77 HCl is a novel, Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist. TG11-77 HCl has a Schild KB of 9.7 nM on EP2, a water solubility of 2.5 mM, a brain-to-plasma ratio of 0.4, and a plasma half-life of 2.4 h in mice. TG11-77 HCl are representative second generation EP2 antagonists with improved pharmacodynamic and pharmacokinetic properties. | |||
T69609 |
TG11-77 free base
|
||
TG11-77 free base is a novel, Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist. TG11-77 free base has a Schild KB of 9.7 nM on EP2, a water solubility of 2.5 mM, a brain-to-plasma ratio of 0.4, and a plasma half-life of 2.4 h in mice. TG11-77 free base are representative second generation EP2 antagonists with improved pharmacodynamic and pharmacokinetic properties. | |||
T69878 |
AA9 TG2 inhibitor
|
||
AA9 is a novel transglutaminase (TG2) inhibitor. | |||
T70413 | TG2-IN-3h | ||
TG2-IN-3h is a highly selective, potent, cell-permeable fluorescent irreversible tissue transglutaminase (tg2) inhibitor | |||
T79505 |
PROTAC TG2 degrader-1
|
PROTACs | PROTAC |
PROTACTG2 degrader-1(化合物 11)是一种靶向组织转谷氨酰胺酶 (TG2) 的VHL基PROTAC,具有68.9 μM的KD值。该化合物通过蛋白酶体途径降低卵巢癌细胞中TG2的水平。 | |||
T69933 |
VA4 TG2 inhibitor
|
||
VA4 is a novel irreversible TG2 transamidase site-specific inhibitor. | |||
T79315 |
PROTAC TG2 degrader-2
|
PROTACs | PROTAC |
PROTACTG2 degrader-2(compound 7)是一种针对Transglutaminase 2(TG2)的选择性竞争性降解剂,其Kd值大于100 μM。该化合物能有效抑制卵巢癌细胞的迁移,并降低其TG2表达水平,因此可作为卵巢癌研究的工具。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00218 |
CXCL7 Protein, Mouse, Recombinant (aa 40-113, His)
b-TG1,pro-platelet basic protein (chemokine (C-X-C ... |
Mouse | E. coli |
CXCL7 Protein, Mouse, Recombinant (aa 40-113, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 10.4 kDa and the accession number is Q9EQI5. | |||
TMPY-00469 |
CXCL7 Protein, Human, Recombinant (His)
LA-PF4,TC1,LDGF,NAP-2,TGB,CTAP-III,PBP,Beta-TG<... |
Human | E. coli |
CXCL7 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 9.9 kDa and the accession number is P02775. |